A retrospective study of molar pregnancy cases submitted to our clinic: 5 years clinical experience

Yıl 2014, Cilt: 5 Sayı: 17, 18 - 23, 03.03.2015

Atilla Karateke Raziye Kurt Mehmet Dede Ayhan Gül Çetin Kılıç Defne Özkaya

https://doi.org/10.17944/mkutfd.18119

Cited By: 1

Öz

Aim: In this study, we aimed to determine the incidence of gestational trophoblastic disease by using data of patients who were treated for molar pregnancies. Material and methods: . The patients diagnosed as gestational trophoblastic disease between January 2009- January 2014 was evaluated retrospectively. Patients’ age, gravidity, parity and aborts were noted. Patients’ history, ultrasonographic findings, β HCG and laboratory results, hystopathology findings, treatment modalities and β HCG for following-up were recorded. Results: The incidence of molar pregnancy was found as 8 per 1000 deliveries. The mean age of patients was 28.72 ±7,5 and mean gestastional week was 10±2,4. β HCG values was found between 240 and 145100. Out of all patients, 20 (33.3%) had ultrasonographic signs of molar pregnancy. Pathology results revealed partial mole in 45 (75%), complete mole in 12 (20%) patients and choriocarcinoma in 3 (5%) patients. No mortality related to disease and complications was observed

Anahtar Kelimeler

Gestational Trophoblastic Disease, incidence, retrospective

KLİNİĞİMİZE BAŞVURAN MOL GEBELİK OLGULARININ RETROSPEKTİF İNCELENMESİ: 5 YILLIK KLİNİK DENEYİM

Öz

Amaç: Bu çalışmada kliniğimizde molar gebelik
tanısıyla tedavi edilen hastaların verileri
kullanılarak gestasyonel trofoblastik hastalıkların
insidansını belirlemeyi amaçladık.
Gereç ve yöntem: Ocak 2009 ve Ocak 2014 yılları
arasında kliniğimizde molar gebelik tanısı almış
hastaların dosyaları retrospektif olarak incelendi.
Hastaların yaş, gravida, parite ve abortus bilgileri
kaydedildi. Olguların hikayesi, ultrasonografi
bulguları, β HCG ile birlikte laboratuar değerleri,
histopatoloji sonuçları, tedavi yöntemleri ve takipte
β HCG değerleri kayıt edildi.

Bulgular: Kliniğimizdeki molar gebelik insidansı
1000 doğumda 5 olarak bulundu. Hastaların
ortalama yaşı 28.72 ±7,5 olup ortalama gestasyonel
yaş 10±2,4 haftaydı. β HCG değerleri 240 ile
145100 arasında değişmekteydi. Hastaların
20’sinde (%33.3) ultrason bulgusu molar gebelik ile
uyumlu izlenmişti. Patoloji sonuçları 45 (%75)
hastada parsiyel mol, 12 (%20) hastada komplet
mol ve 3 (%5) hastada koryokarsinom gelmiştir.
Olgularda hastalık ve komplikasyonlarına ait ölüm
olgusuna rastlanmamıştır.
Sonuç: Kliniğimizde gestasyonel trofoblastik
hastalık insidansı 1000 doğumda 5 olup daha kesin
bir insidansa ulaşmak için ileri düzeyde araştırmalar
yapılması gerekmektedir.

Anahtar Kelimeler

Gestasyonel trofoblastik hastalık, insidans, MOL

Kaynakça

• Kohorn EI. Negotiating a staging and risk factor scoring system for gestational trophoblastic
• neoplasia. A progress report. The Journal of reproductive medicine. 2002;47(6):445-50.
• Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases.
• Gynecologic oncology. 2009;112(3):654-62.
• Davis JR, Surwit EA, Garay JP, Fortier KJ. Sex assignment in gestational trophoblastic
• neoplasia. American journal of obstetrics and gynecology. 1984;148(6):722-5.
• Surti U, Szulman AE, O'Brien S. Dispermic origin and clinical outcome of three complete
• hydatidiform moles with 46,XY karyotype. American journal of obstetrics and gynecology.
• ;144(1):84-7.
• Hammond CB, Evans AC. Gestational trophoblastic disease. Current therapy in endocrinology
• and metabolism. 1997;6:603-6.
• Tham BW, Everard JE, Tidy JA, Drew D, Hancock BW. Gestational trophoblastic disease in
• the Asian population of Northern England and North Wales. BJOG : an international journal of
• obstetrics and gynaecology. 2003;110(6):555-9.
• Lybol C, Centen DW, Thomas CM, ten Kate-Booij MJ, Verheijen RH, Sweep FC, et al. Fatal
• cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective
• cohort study. BJOG : an international journal of obstetrics and gynaecology. 2012;119(12):1465-72.
• Cakmak B, Toprak M, Nacar MC, Koseoglu RD, Guneri N. Incidence of gestational
• trophoblastic disease in Tokat province, Turkey. Journal of the Turkish German Gynecological
• Association. 2014;15(1):22-4.
• Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet.
• ;376(9742):717-29.
• Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. The Journal of
• reproductive medicine. 1994;39(3):155-62.
• Therasakvichya S. Gestational trophoblastic disease in 2005. Journal of the Medical
• Association of Thailand = Chotmaihet thangphaet. 2005;88 Suppl 2:S119-23.
• Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean
• experience. The Journal of reproductive medicine. 1998;43(1):60-8.
• Hayashi K, Bracken MB, Freeman DH, Jr., Hellenbrand K. Hydatidiform mole in the United
• States (1970-1977): a statistical and theoretical analysis. American journal of epidemiology.
• ;115(1):67-77.
• Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete
• hydatidiform molar pregnancy in relation to maternal age. BJOG : an international journal of
• obstetrics and gynaecology. 2002;109(1):99-102.
• Sand PK, Lurain JR, Brewer JI. Repeat gestational trophoblastic disease. Obstetrics and
• gynecology. 1984;63(2):140-4.
• Tierney JP, Welsh J, Owen P. Management of early pregnancy loss--a complete audit cycle.
• Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.
• ;26(3):229-32.
• Hou JL, Wan XR, Xiang Y, Qi QW, Yang XY. Changes of clinical features in hydatidiform
• mole: analysis of 113 cases. The Journal of reproductive medicine. 2008;53(8):629-33.
• Nayeri UA, West AB, Grossetta Nardini HK, Copel JA, Sfakianaki AK. Systematic review of
• sonographic findings of placental mesenchymal dysplasia and subsequent pregnancy outcome.
• Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound
• in Obstetrics and Gynecology. 2013;41(4):366-74.
• Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Routine pre-evacuation ultrasound diagnosis of
• hydatidiform mole: experience of more than 1000 cases from a regional referral center. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics
• and Gynecology. 2006;27(1):56-60.
• Sebire NJ, Rees H, Paradinas F, Seckl M, Newlands E. The diagnostic implications of routine
• ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound in obstetrics
• & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and
• Gynecology. 2001;18(6):662-5.
• Berkowitz RS. Gestational trophoblastic tumors and malignant ovarian germ cell tumors.
• Current opinion in oncology. 1989;1(1):119-22.
• Kerkmeijer L, Wielsma S, Bekkers R, Pyman J, Tan J, Quinn M. Guidelines following
• hydatidiform mole: a reappraisal. The Australian & New Zealand journal of obstetrics & gynaecology.
• ;46(2):112-8.